Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03181178Not ApplicableCompleted

Effect of a Complementary Food Supplement on Growth and Morbidity of Ghanaian Infants

Role: lead

NCT00824304Completed

Long-term Effects of Iron and Zinc Supplementation During Infancy on Cognitive Performance and Growth

Role: collaborator

NCT01224535Not ApplicableCompleted

Improving Iron Status of Children: Potential of Amaranth

Role: collaborator

All 3 trials loaded